● In Stock

Semax

🧪 ≥99% Purity | HPLC Verified
$60.00
🔒 Secure Checkout
🔬 Third-Party Tested
Money-Back Guarantee
PASSED Sterility & Endotoxins
PASSED Net Content & Purity
🧪 Purity: ≥99%
❄️ Store at -20°C

ACTH(4-7) analog studied for cognitive enhancement and neuroprotection in clinical research. Research use only.

Research Use OnlyNot for human or veterinary use. For in vitro laboratory research only.
Strength 5mg
molecular_formula C37H51N9O10S
Molecular Weight 813.93 g/mol
Purity >99% (HPLC)
Form Lyophilized Powder
🧠
1.4×
BDNF Increase
Brain-derived neurotrophic factor
🔬
7
Amino Acids
ACTH(4-10) synthetic analog
🏥
2011
Approved in Russia
Prescription nootropic since 2011
99%+
Purity Verified
HPLC tested, COA included
🔬
How Semax Works
Neuropeptide derived from ACTH with cognitive-enhancing and neuroprotective properties
Neurotrophic
BDNF Modulation
Semax increases brain-derived neurotrophic factor (BDNF) levels by up to 1.4-fold in specific brain regions, supporting neuronal survival, growth, and synaptic plasticity.
  • Increases BDNF expression up to 1.4×
  • Supports neuronal survival and growth
  • Enhances synaptic plasticity
Neurotransmitter
Serotonin & Dopamine Modulation
Research demonstrates Semax modulates serotonergic and dopaminergic systems, influencing mood regulation, attention, and cognitive processing in preclinical models.
  • Modulates serotonin metabolism
  • Influences dopaminergic signaling
  • Affects noradrenergic pathways
Neuroprotective
Ischemic Protection
In ischemic stroke models, Semax demonstrates neuroprotective effects by reducing infarct volume, modulating inflammatory gene expression, and promoting neuronal survival under oxygen deprivation.
  • Reduces infarct volume in stroke models
  • Anti-inflammatory gene modulation
  • Protects neurons from oxidative stress
📊
What Research Has Shown
Key findings from preclinical and clinical studies
BDNF Expression Increase140%
Cognitive Performance (animal)65%
Neuroprotection (ischemia)78%
Anti-Inflammatory Effect60%
🎯
Research Applications
Areas of active preclinical and clinical investigation
Cognitive
Memory & Learning
Enhances cognitive function, memory consolidation, and attention in animal models. Approved as a nootropic in Russia since 2011.

Ashmarin et al. 2006 ↗

Neuroprotection
Stroke Recovery
Reduces ischemic brain damage and promotes neuronal survival in cerebral ischemia models. Used clinically in Russia for stroke recovery.

Gusev et al. 2010 ↗

Neurotrophic
BDNF & Nerve Growth
Modulates expression of neurotrophins and their receptors, supporting neuronal plasticity and regeneration pathways.

Agapova et al. 2010 ↗

Anti-Inflammatory
Immune Modulation
Reduces pro-inflammatory cytokines and modulates oxidative stress-related gene expression in hippocampal tissue.

Agapova et al. 2011 ↗

🛡️
Safety Profile from Research
Clinical and preclinical safety data
Approved as a prescription medication in Russia and CIS countries since 2011 with established clinical safety data.
Derived from ACTH(4-10), a naturally occurring fragment of adrenocorticotropic hormone with no corticosteroid activity.
Does not affect cortisol levels — unlike ACTH itself, Semax has no adrenal stimulating properties.
No significant adverse effects reported in published Russian clinical literature at approved dosages.
⚠️ Semax is not FDA approved in the United States. Available for in vitro research only. Not for human consumption outside approved jurisdictions.
📋
Compound Information
Technical specifications
Sequence Met-Glu-His-Phe-Pro-Gly-Pro
Molecular Weight 813.93 Da
Origin Synthetic analog of ACTH(4-10)
Form Lyophilized powder
Purity ≥99% (HPLC verified)
Testing Third-party HPLC, Mass Spec, Endotoxin
Storage (lyophilized) -20°C for up to 24 months
Storage (reconstituted) 2–8°C, use within 21 days
Solubility Bacteriostatic water for reconstitution
COA Included with every order
Frequently Asked Questions
Common questions about Semax

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide derived from the first four amino acids of adrenocorticotropic hormone (ACTH 4-10). It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s and has been approved in Russia as a prescription nootropic since 2011.

Research has demonstrated that Semax may increase BDNF levels by up to 1.4-fold, modulate serotonergic and dopaminergic systems, have neuroprotective effects in ischemic stroke models, enhance cognitive function and memory in animal studies, and display anti-inflammatory properties.

Semax is not approved by the FDA for any medical use in the United States. It is approved in Russia as a prescription medication for cognitive disorders and stroke recovery. In the US, it is available only as a research peptide for in vitro laboratory use.

N-Acetyl Semax (NASA) has an acetyl group added to the N-terminus, increasing stability and resistance to enzymatic degradation. This results in a longer half-life and potentially enhanced bioavailability compared to standard Semax.

Lyophilized Semax should be stored at -20°C for long-term stability (up to 24 months). After reconstitution, store at 2-8°C and use within 21 days. Protect from heat and direct light.
📚

Sources & References

PubMed
Semax, an ACTH(4-10) analogue with cognitive-enhancing properties
2006
Ashmarin IP et al.

View Source ↗

PubMed
Neuroprotective effects of Semax in conditions of cerebral ischemia
2010
Gusev EI et al.

View Source ↗

PubMed
Semax modulates the expression of neurotrophins and their receptors
2010
Agapova TYu et al.

View Source ↗

PubMed
Molecular mechanisms underlying effects of Semax on hippocampal gene expression
2011
Agapova TYu et al.

View Source ↗

Published research on this compound is available through PubMed and other scientific databases.

Certificate of Analysis

Analysis Date: Available on request
Lot Number: Batch-specific
Purity: >99% (HPLC)

Third-Party Testing

  • ✓ Identity verification (Mass Spectrometry)
  • ✓ Purity analysis (HPLC)
  • ✓ Sterility testing
  • ✓ Endotoxin screening

Storage Conditions

  • Lyophilized: Store at -20°C, protected from light
  • Reconstituted: Store at 2-8°C, use within 30 days
  • Stability: 24 months from manufacture date when stored properly

Handling Guidelines

  • Use sterile technique when reconstituting
  • Allow vial to reach room temperature before opening
  • Reconstitute with bacteriostatic water or sterile saline
  • Avoid repeated freeze-thaw cycles
🔬
3D Structure

Semax

This compound has been extensively studied in peer-reviewed literature. Eon Peptides provides this product exclusively for legitimate in-vitro research and analytical applications.

  • High-purity research compound
  • Full analytical documentation included
  • Third-party verification available
ℹ️ PRODUCT SPECIFICATIONS

LOT DATA

Lot Number Assigned on shipment
Verified Purity >99%
Quantity 5mg

MOLECULAR DATA

Molecular Formula Available on request
Form Lyophilized Powder
Appearance White to off-white powder